DILON Diagnostics and GE Healthcare announce the FDA clearance of the Discovery NM 750b biopsy accessory
Juggernaut Announces Strategic Investment by Crescat Capital Funds for 28.95% Ownership - Dr. Quinton Hennigh Technical Advisor